This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rauch, P. Articles by Guillemin, F. Search for Related Content PubMed PubMed Citation Articles by Rauch, P. Articles by Guillemin, F. Social Bookmarking                            What's this?

Quality of Life Among Disease-Free Survivors of Rectal Cancer

From the Surgical Department and Medical Oncology Department, Centre Alexis Vautrin; the School of Public Health and Medicine University, Vandoeuvre lès Nancy; and the Radiotherapy Department, University Hospital, Besançon, France

Address reprint requests to Philippe Rauch, MD, Centre Alexis Vautrin, 54511 Vandoeuvre lès Nancy, France; e-mail: p.rauch{at}nancy.fnclcc.fr

PURPOSE: To identify factors affecting the quality of life (QoL) of disease-free survivors of rectal cancer.

PATIENTS AND METHODS: One hundred twenty-one patients in complete remission more than 2 years after diagnosis were asked to complete three QoL questionnaires: the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30; its colorectal module, QLQ-CR38; and the Duke generic instrument.

RESULTS: Patients reported less pain (P = .002) than did controls drawn from the general population. EORTC QLQ-C30 physical scores were also higher among rectal cancer survivors than in the general Norwegian or German population (P = .0005 and P = .002, respectively). Unexpectedly, stoma patients reported better social functioning than did nonstoma patients (P = .005), with less anxiety (P = .008) and higher self-esteem (P = .0002). In the present authors' experience, the QLQ-CR38 does not discriminate between these groups. Residual abdominal or pelvic pain and constipation had the most negative influence on QoL.

CONCLUSION: QoL is high among rectal cancer survivors, including stoma patients. Simultaneous use of several QoL questionnaires appears to have value in follow-up and in monitoring the effects of therapy. The impact of residual pain and constipation on long-term QoL should be considered when establishing a treatment regimen.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. S. Krouse, L. J. Herrinton, M. Grant, C. S. Wendel, S. B. Green, M. J. Mohler, C. M. Baldwin, C. K. McMullen, S. M. Rawl, E. Matayoshi, et al. Health-Related Quality of Life Among Long-Term Rectal Cancer Survivors With an Ostomy: Manifestations by Sex J. Clin. Oncol., October 1, 2009; 27(28): 4664 - 4670. [Abstract] [Full Text] [PDF]

				J. A. Martenson, M. Y. Halyard, J. A. Sloan, G. M. Proulx, R. C. Miller, R. L. Deming, S. J. Dick, H. A. Johnson, T.H. P. Tai, A. W. Zhu, et al. Phase III, Double-Blind Study of Depot Octreotide Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy: Results of North Central Cancer Treatment Group N00CA J. Clin. Oncol., November 10, 2008; 26(32): 5248 - 5253. [Abstract] [Full Text] [PDF]

				J. A. Talcott Prostate Cancer Quality of Life: Beyond Initial Treatment and the Patient J. Clin. Oncol., September 20, 2007; 25(27): 4155 - 4156. [Full Text] [PDF]

				V. Arndt, H. Merx, C. Stegmaier, H. Ziegler, and H. Brenner Quality of Life in Patients With Colorectal Cancer 1 Year After Diagnosis Compared With the General Population: A Population-Based Study J. Clin. Oncol., December 1, 2004; 22(23): 4829 - 4836. [Abstract] [Full Text] [PDF]